Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS)

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Sporadic Amyotrophic Lateral Sclerosis
Interventions
DRUG

Mexiletine

DRUG

Placebo

Trial Locations (10)

13210

SUNY Upstate Medical Center, Syracuse

17033

Penn State Hershey Medical Center, Hershey

52242

University of Iowa, Iowa City

63110

Washington University Medical School, St Louis

66160

University of Kansas Medical Center, Kansas City

90095

UCLA, Neuromuscular Research Center, Los Angeles

98195

University of Washington Medical Center, Seattle

02114

Massachusetts General Hospital, Boston

01655

University of Massachusetts (Worcester) Memorial Medical Center, Worcester

75390-8897

University of Texas Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
lead

University of Washington

OTHER

NCT01849770 - Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS) | Biotech Hunter | Biotech Hunter